Hyperfine (HYPR) Depreciation & Amortization (CF) (2021 - 2026)
Hyperfine posted quarterly Depreciation & Amortization (CF) of $274000.0 for Q1 2026, up 19.65% year-on-year from $229000.0 in Q1 2025, and down 2.49% on a QoQ basis from $281000.0 in Q4 2025.
Hyperfine (HYPR) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $274000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 19.65% year-over-year to $274000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 16.41% YoY), and the FY2025 full-year result was $1.1 million, up 8.03% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $274000.0, down from $281000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $297000.0 in Q3 2025 and bottomed at $229000.0 in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $261000.0 (2022), against an average of $261294.1.
- Peak annual rise in Depreciation & Amortization (CF) reached 163.54% in 2022, while the deepest fall reached 22.55% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $261000.0 in 2022, then grew by 0.77% to $263000.0 in 2023, then slipped by 11.03% to $234000.0 in 2024, then climbed by 20.09% to $281000.0 in 2025, then slipped by 2.49% to $274000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $274000.0 (Q1 2026), $281000.0 (Q4 2025), and $297000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | 274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Sep 30, 2025 | 297,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Mar 31, 2024 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 259,000.00 |
| Jun 30, 2023 | 259,000.00 |
| Mar 31, 2023 | 254,000.00 |
| Mar 31, 2023 | 254,000.00 |
| Dec 31, 2022 | 261,000.00 |
| Dec 31, 2022 | 261,000.00 |
| Sep 30, 2022 | 238,000.00 |
| Sep 30, 2022 | 238,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 337,000.00 |
| Dec 31, 2021 | 337,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 122,000.00 |
| Jun 30, 2021 | 122,000.00 |
| Mar 31, 2021 | 96,000.00 |
| Mar 31, 2021 | 96,000.00 |